MDXL — Medixall Share Price
0.000.00%
Last trade - 00:00- $0.85m
- $4.67m
- $0.31m
- 39
- 16
- 82
- 43
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.73 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -1474.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0 | n/a | 0.01 | 0.06 | 0.31 | n/a | n/a | 178.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MediXall Group, Inc. is a solutions company that provides practical, value-based, customized solutions to individual members, employers, and organizations which enhance their overall physical health, mental health and well-being, increase productivity, and help control the cost of care of the individual, the employer, or organization. The Company’s solutions include Behavioral 1st Moment Solution, Workers 1st Moment Solution, Responders 1st Moment Solution, and Academic 1st Moment Solution for students, faculty, and staff. The solutions are offered through its subsidiary, Health Karma Inc. (Health Karma). Its Behavioral 1st Moment Solutions include various options to both its member and their immediate family. Its Workers 1st Moment Solution is a pre-claim, preemptive, 24/7/365 solution for both physical and mental injuries and incidences to reduce work comp claims, costs, fraud, and unnecessary and over-utilized case management. It also offers customizable 1st Moment Solutions.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 21st, 1998
- Public Since
- January 16th, 2003
- No. of Shareholders
- 955
- No. of Employees
- 7
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 216,670,067
- Address
- 104 N 4TH ST., LEESBURG, 34748
- Web
- https://www.medixallgroup.com/
- Phone
- +1 9544404678
- Auditors
- Hacker, Johnson & Smith PA
Upcoming Events for MDXL
Q2 2025 Medixall Group Inc Earnings Release
Q3 2025 Medixall Group Inc Earnings Release
Similar to MDXL
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
Aesthetic Medical International Holdings
Pink Sheets on Nasdaq
FAQ
What is the Medixall share price?
As of Today at 03:57 UTC, shares in Medixall are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Medixall share price performed this year?
Shares in Medixall last closed at $0.00 and the price had moved by +389900% over the past 365 days. In terms of relative price strength the Medixall share price has outperformed the S&P500 Index by +364263.82% over the past year.
What are the analyst and broker recommendations for Medixall?
There is no consensus recommendation for this security.
Find out moreWhat is the Medixall dividend yield?
Medixall does not currently pay a dividend.
Does Medixall pay a dividend?
Medixall does not currently pay a dividend.
When does Medixall next pay dividends?
Medixall does not currently pay a dividend.
How do I buy Medixall shares?
To buy shares in Medixall you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medixall?
As of the previous close price of $0.00, shares in Medixall had a market capitalisation of $0.85m.
Where are Medixall shares listed?
Here are the trading details for Medixall:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: MDXL
What kind of share is Medixall?
Based on an overall assessment of its quality, value and momentum Medixall is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medixall share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Medixall share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medixall. Over the past six months, its share price has outperformed the S&P500 Index by +572.85%.
As of the last closing price of $0.00, shares in Medixall were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medixall PE Ratio?
The Medixall PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medixall?
Medixall's management team is headed by:
- Neil Swartz - CHM
- Timothy Hart - CFO
- Noel Guillama - IND